CSTL Jul 2024 20.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

3.0500

0.0000

(0.00%)

As of 03:32PM EDT. Market open.

Loading interactive chart…

Business Wire
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner
FRIENDSWOOD, Texas, June 14, 2024--Castle's founder, president & CEO, Derek Maetzold, has been named an EY 2024 Entrepreneur Of The Year® for the Gulf South region
Zacks
Is Castle Biosciences (CSTL) Outperforming Other Medical Stocks This Year?
Here is how Castle Biosciences, Inc. (CSTL) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
Business Wire
Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance
FRIENDSWOOD, Texas, May 30, 2024--Castle will present new data related to its DecisionDx-Melanoma and DecisionDx-UM tests at the 2024 ASCO Annual Meeting, May 31-June 4, 2024.